Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy

ClinicalTrials.gov ID: NCT00445003

Public ClinicalTrials.gov record NCT00445003. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to find out if treatment with an intravitreal injection of triamcinolone or an intravitreal injection of ranibizumab can prevent loss of vision caused by panretinal photocoagulation treatment. At the present time, it is not known whether intravitreal steroid or anti-vascular endothelial growth factor (anti-VEGF) injections are beneficial in preventing vision loss after panretinal photocoagulation (PRP) treatment. It is possible that one or both of the types of injections will prevent vision loss after PRP treatment. However, it is not known whether the benefits of the injections will outweigh the risks. It is possible that because of side effects, the injections may not be as good as laser alone in treating the diabetic retinopathy.

Study identification

NCT ID
NCT00445003
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
333 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2007 (Type not available)
Primary completion
Oct 2009 (Actual)
Completion
Jul 2010 (Actual)
Last update posted
Aug 26, 2016

2007 – 2010

United States locations

U.S. sites
56
U.S. states
25
U.S. cities
49
Facility City State ZIP Site status
Sall Research Medical Center Artesia California 90701 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
University of California, Irvine Irvine California 92697 —
Loma Linda University Health Care, Dept. of Ophthalmology Loma Linda California 92354 —
Southern California Desert Retina Consultants, MC Palm Springs California 92262 —
California Retina Consultants Santa Barbara California 93103 —
Bay Area Retina Associates Walnut Creek California 94598 —
Eldorado Retina Associates, P.C. Louisville Colorado 80027 —
Retina Vitreous Consultants Fort Lauderdale Florida 33334 —
Retina Consultants of Southwest Florida Fort Myers Florida 33912 —
Central Florida Retina Institute Lakeland Florida 33805 —
Southeast Retina Center, P.C. Augusta Georgia 30909 —
University of Illinois at Chicago Medical Center Chicago Illinois 60612 —
Illinois Retina Associates Joliet Illinois 60435 —
Raj K. Maturi, M.D., P.C. Indianapolis Indiana 46280 —
John-Kenyon American Eye Institute New Albany Indiana 47150 —
Medical Associates Clinic, P.C. Dubuque Iowa 52002 —
Paducah Retinal Center Paducah Kentucky 42001 —
Maine Vitreoretinal Consultants Bangor Maine 04401 —
Elman Retina Group, P.A. Baltimore Maryland 21237 —
Wilmer Ophthalmological Institute at Johns Hopkins Baltimore Maryland 21287-9277 —
Retina Consultants of Delmarva, P.A. Salisbury Maryland 21801 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Joslin Diabetes Center Boston Massachusetts 02215 —
Retina Center, PA Minneapolis Minnesota 55404 —
University of Minnesota Minneapolis Minnesota 55455 —
Eyesight Ophthalmic Services, PA Portsmouth New Hampshire 03801 —
The New York Eye and Ear Infirmary/Faculty Eye Practice New York New York 10003 —
Retina-Vitreous Surgeons of Central New York, PC Syracuse New York 13224 —
University of North Carolina, Dept of Ophthalmology Chapel Hill North Carolina 27599-7040 —
Charlotte Eye, Ear, Nose and Throat Assoc., PA Charlotte North Carolina 28210 —
Horizon Eye Care, PA Charlotte North Carolina 28211 —
Wake Forest University Eye Center Winston-Salem North Carolina 27157 —
Case Western Reserve University Cleveland Ohio 44106 —
OSU Eye Physicians and Surgeons, LLC. Dublin Ohio 43017 —
Retina Northwest, PC Portland Oregon 97210 —
Casey Eye Institute Portland Oregon 97239 —
Penn State College of Medicine Hershey Pennsylvania 17033 —
University of Pennsylvania Scheie Eye Institute Philadelphia Pennsylvania 19104 —
Retina Consultants Providence Rhode Island 02903 —
Palmetto Retina Center Columbia South Carolina 29169 —
Carolina Retina Center Columbia South Carolina 29223 —
Southeastern Retina Associates, PC Kingsport Tennessee 37660 —
Southeastern Retina Associates, P.C. Knoxville Tennessee 37909 —
West Texas Retina Consultants P.A. Abilene Texas 79605 —
Texas Retina Associates Arlington Texas 76012 —
Retina Research Center Austin Texas 78705 —
Texas Retina Associates Dallas Texas 75231 —
Retina and Vitreous of Texas Houston Texas 77025 —
Vitreoretinal Consultants Houston Texas 77030 —
Texas Retina Associates Lubbock Texas 79424 —
Valley Retina Institute McAllen Texas 78503 —
Retinal Consultants of San Antonio San Antonio Texas 78240 —
Virginia Retina Center Leesburg Virginia 20176 —
University of Washington Medical Center Seattle Washington 98195 —
University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00445003, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00445003 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →